Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistant Epilepsy | 7 | 2026 | 287 | 2.030 |
Why?
|
| Electroencephalography | 6 | 2026 | 863 | 1.610 |
Why?
|
| Epilepsy | 8 | 2023 | 876 | 1.420 |
Why?
|
| Tuberous Sclerosis | 4 | 2025 | 147 | 1.290 |
Why?
|
| Status Epilepticus | 2 | 2024 | 159 | 1.110 |
Why?
|
| Seizures | 9 | 2026 | 890 | 1.090 |
Why?
|
| Clinical Decision-Making | 1 | 2026 | 314 | 0.770 |
Why?
|
| Anticonvulsants | 2 | 2024 | 363 | 0.540 |
Why?
|
| Laser Therapy | 3 | 2025 | 243 | 0.510 |
Why?
|
| Propylene Glycols | 1 | 2015 | 18 | 0.460 |
Why?
|
| Phenylcarbamates | 1 | 2015 | 14 | 0.460 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2015 | 28 | 0.450 |
Why?
|
| Ataxia | 2 | 2023 | 160 | 0.450 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 2 | 2025 | 9 | 0.440 |
Why?
|
| Intellectual Disability | 3 | 2022 | 1089 | 0.440 |
Why?
|
| Ocular Motility Disorders | 1 | 2015 | 38 | 0.440 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 81 | 0.430 |
Why?
|
| Phosphotransferases (Phosphomutases) | 1 | 2012 | 7 | 0.380 |
Why?
|
| Neurodevelopmental Disorders | 4 | 2025 | 629 | 0.370 |
Why?
|
| Sleep Wake Disorders | 1 | 2015 | 204 | 0.370 |
Why?
|
| Microcephaly | 1 | 2015 | 347 | 0.360 |
Why?
|
| Homicide | 1 | 2012 | 34 | 0.360 |
Why?
|
| Developmental Disabilities | 3 | 2025 | 781 | 0.360 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2012 | 50 | 0.360 |
Why?
|
| Epilepsy, Generalized | 2 | 2023 | 63 | 0.350 |
Why?
|
| Suicide | 1 | 2012 | 208 | 0.300 |
Why?
|
| Child Abuse | 1 | 2012 | 228 | 0.290 |
Why?
|
| Stereotaxic Techniques | 2 | 2025 | 102 | 0.270 |
Why?
|
| Child | 13 | 2026 | 26341 | 0.240 |
Why?
|
| Genetic Testing | 1 | 2013 | 1106 | 0.240 |
Why?
|
| Vigabatrin | 1 | 2024 | 19 | 0.210 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2023 | 13 | 0.200 |
Why?
|
| Brain Mapping | 1 | 2026 | 384 | 0.200 |
Why?
|
| Myoclonus | 1 | 2023 | 31 | 0.200 |
Why?
|
| Hemispherectomy | 1 | 2023 | 28 | 0.190 |
Why?
|
| Child, Preschool | 10 | 2025 | 15110 | 0.190 |
Why?
|
| Landau-Kleffner Syndrome | 1 | 2022 | 6 | 0.190 |
Why?
|
| Dystonic Disorders | 1 | 2023 | 92 | 0.180 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2022 | 16 | 0.180 |
Why?
|
| Adaptation, Psychological | 1 | 2025 | 431 | 0.180 |
Why?
|
| Humans | 20 | 2026 | 131163 | 0.180 |
Why?
|
| Dystonia | 1 | 2023 | 165 | 0.170 |
Why?
|
| Infant | 6 | 2025 | 13352 | 0.170 |
Why?
|
| Treatment Outcome | 6 | 2025 | 12936 | 0.160 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2019 | 25 | 0.150 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 450 | 0.150 |
Why?
|
| Brain Waves | 1 | 2019 | 42 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2025 | 3763 | 0.130 |
Why?
|
| Male | 11 | 2025 | 64957 | 0.130 |
Why?
|
| Female | 12 | 2025 | 70963 | 0.130 |
Why?
|
| Child Development | 1 | 2019 | 266 | 0.120 |
Why?
|
| Retrospective Studies | 8 | 2025 | 17753 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 445 | 0.120 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8635 | 0.120 |
Why?
|
| Adolescent | 7 | 2025 | 20987 | 0.110 |
Why?
|
| Disease Progression | 1 | 2019 | 2200 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 325 | 0.090 |
Why?
|
| Newspapers as Topic | 1 | 2012 | 6 | 0.090 |
Why?
|
| Child of Impaired Parents | 1 | 2012 | 20 | 0.090 |
Why?
|
| Eye Movements | 1 | 2012 | 69 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2014 | 516 | 0.090 |
Why?
|
| Gain of Function Mutation | 2 | 2023 | 115 | 0.090 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 82 | 0.090 |
Why?
|
| Suicide, Attempted | 1 | 2012 | 150 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2014 | 697 | 0.080 |
Why?
|
| Phenotype | 2 | 2025 | 4497 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 819 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 3829 | 0.080 |
Why?
|
| Cause of Death | 1 | 2012 | 506 | 0.080 |
Why?
|
| Sex Factors | 1 | 2012 | 1356 | 0.070 |
Why?
|
| Young Adult | 3 | 2025 | 10103 | 0.060 |
Why?
|
| Mutation | 3 | 2025 | 6099 | 0.060 |
Why?
|
| Magnetoencephalography | 1 | 2025 | 44 | 0.060 |
Why?
|
| Electrodes, Implanted | 1 | 2025 | 180 | 0.050 |
Why?
|
| Incidence | 1 | 2012 | 3360 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2012 | 910 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 1 | 2025 | 271 | 0.050 |
Why?
|
| Qb-SNARE Proteins | 1 | 2023 | 6 | 0.050 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2025 | 134 | 0.050 |
Why?
|
| 4-Aminopyridine | 1 | 2023 | 28 | 0.050 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2023 | 39 | 0.050 |
Why?
|
| Spasms, Infantile | 1 | 2025 | 166 | 0.050 |
Why?
|
| Adult | 3 | 2025 | 31282 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2025 | 801 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2022 | 57 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 260 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2022 | 167 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2022 | 363 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2025 | 919 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2025 | 1029 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2304 | 0.040 |
Why?
|
| Chromosome Deletion | 1 | 2022 | 653 | 0.040 |
Why?
|
| Sleep | 1 | 2022 | 381 | 0.040 |
Why?
|
| Risk Factors | 1 | 2012 | 11074 | 0.030 |
Why?
|
| Aggression | 1 | 2019 | 218 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2022 | 963 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2025 | 5196 | 0.030 |
Why?
|
| United States | 1 | 2012 | 12072 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2025 | 5063 | 0.030 |
Why?
|
| Middle Aged | 2 | 2014 | 28601 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1490 | 0.030 |
Why?
|
| Neurons | 1 | 2025 | 1979 | 0.030 |
Why?
|
| Facies | 1 | 2014 | 157 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2014 | 353 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 743 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 1046 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 3385 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 1833 | 0.020 |
Why?
|
| Animals | 1 | 2025 | 33912 | 0.010 |
Why?
|
| Brain | 1 | 2014 | 3175 | 0.010 |
Why?
|